Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,870
archived clinical trials in
Pain

An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
740
mi
from 43215
Biloxi, MS
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
740
mi
from 43215
Biloxi, MS
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
400
mi
from 43215
Hazelwood, MO
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
400
mi
from 43215
Hazelwood, MO
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
618
mi
from 43215
Kansas City, MO
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
585
mi
from 43215
Springfield, MO
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
585
mi
from 43215
Springfield, MO
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
1344
mi
from 43215
Billings, MT
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
1344
mi
from 43215
Billings, MT
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
682
mi
from 43215
Omaha, NE
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
1767
mi
from 43215
Las Vegas, NV
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
1767
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
428
mi
from 43215
Berlin, NJ
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
428
mi
from 43215
Berlin, NJ
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
421
mi
from 43215
Blackwood, NJ
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
421
mi
from 43215
Blackwood, NJ
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
1333
mi
from 43215
Albuquerque, NM
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
493
mi
from 43215
Manhasset, NY
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
493
mi
from 43215
Manhasset, NY
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
481
mi
from 43215
New York, NY
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
321
mi
from 43215
Greensboro, NC
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
321
mi
from 43215
Greensboro, NC
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
322
mi
from 43215
High Point, NC
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
322
mi
from 43215
High Point, NC
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
857
mi
from 43215
Fargo, ND
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
857
mi
from 43215
Fargo, ND
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
64
mi
from 43215
Dayton, OH
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
64
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
63
mi
from 43215
Kettering, OH
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
63
mi
from 43215
Kettering, OH
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
79
mi
from 43215
Tiffin, OH
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
79
mi
from 43215
Tiffin, OH
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
143
mi
from 43215
Willoughby, OH
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
143
mi
from 43215
Willoughby, OH
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
2057
mi
from 43215
Eugene, OR
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
2057
mi
from 43215
Eugene, OR
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
2058
mi
from 43215
Medford, OR
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
2058
mi
from 43215
Medford, OR
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
2026
mi
from 43215
Portland, OR
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
2044
mi
from 43215
Salem, OR
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
2044
mi
from 43215
Salem, OR
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
252
mi
from 43215
Tipton, PA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
252
mi
from 43215
Tipton, PA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
373
mi
from 43215
Wyomissing, PA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
373
mi
from 43215
Wyomissing, PA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
378
mi
from 43215
Anderson, SC
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
378
mi
from 43215
Anderson, SC
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
367
mi
from 43215
Fountain Inn, SC
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
367
mi
from 43215
Fountain Inn, SC
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
351
mi
from 43215
Greer, SC
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
351
mi
from 43215
Greer, SC
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
720
mi
from 43215
Dakota Dunes, SD
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
720
mi
from 43215
Dakota Dunes, SD
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
1071
mi
from 43215
Rapid City, SD
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
1071
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
283
mi
from 43215
Knoxville, TN
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
283
mi
from 43215
Knoxville, TN
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
245
mi
from 43215
New Tazewell, TN
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
245
mi
from 43215
New Tazewell, TN
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
362
mi
from 43215
Tullahoma, TN
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
362
mi
from 43215
Tullahoma, TN
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
910
mi
from 43215
Dallas, TX
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
1130
mi
from 43215
Lubbock, TX
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
1130
mi
from 43215
Lubbock, TX
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
896
mi
from 43215
Plano, TX
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
896
mi
from 43215
Plano, TX
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
437
mi
from 43215
Virginia Beach, VA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
437
mi
from 43215
Virginia Beach, VA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
1998
mi
from 43215
Bellevue, WA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
1998
mi
from 43215
Bellevue, WA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
1912
mi
from 43215
Wenatchee, WA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
1912
mi
from 43215
Wenatchee, WA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
9459
mi
from 43215
Camperdown,
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
9459
mi
from 43215
Camperdown,
Click here to add this to my saved trials